acetazolamide has been researched along with Exfoliation Glaucoma in 7 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Excerpt | Relevance | Reference |
---|---|---|
"To examine whether intraocular pressure (IOP) increases immediately after cataract surgery in eyes with pseudoexfoliation (PXF) syndrome and to assess whether orally administered acetazolamide can prevent the IOP elevation." | 9.27 | Intraocular pressure elevation after cataract surgery and its prevention by oral acetazolamide in eyes with pseudoexfoliation syndrome. ( Hayashi, K; Manabe, SI; Sato, T; Yoshida, M; Yoshimura, K, 2018) |
"To examine whether intraocular pressure (IOP) increases immediately after cataract surgery in eyes with pseudoexfoliation (PXF) syndrome and to assess whether orally administered acetazolamide can prevent the IOP elevation." | 5.27 | Intraocular pressure elevation after cataract surgery and its prevention by oral acetazolamide in eyes with pseudoexfoliation syndrome. ( Hayashi, K; Manabe, SI; Sato, T; Yoshida, M; Yoshimura, K, 2018) |
"After 7 months of treatment for bilateral panuveitis with topical steroid and tropicamide, the patient developed a thin, transparent membrane arising on the lens surface in the right eye." | 3.70 | True exfoliation of the lens capsule following uveitis. ( Miyagawa, A; Yamamoto, N, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, K | 2 |
Yoshida, M | 2 |
Sato, T | 1 |
Manabe, SI | 2 |
Yoshimura, K | 2 |
Ă–zcura, F | 1 |
Dayanir, V | 1 |
Ritland, JS | 2 |
Egge, K | 2 |
Lydersen, S | 2 |
Juul, R | 2 |
Semb, SO | 2 |
McKibbin, M | 1 |
Gupta, A | 1 |
Atkins, AD | 1 |
Yamamoto, N | 1 |
Miyagawa, A | 1 |
1 trial available for acetazolamide and Exfoliation Glaucoma
Article | Year |
---|---|
Intraocular pressure elevation after cataract surgery and its prevention by oral acetazolamide in eyes with pseudoexfoliation syndrome.
Topics: Acetazolamide; Administration, Oral; Aged; Carbonic Anhydrase Inhibitors; Exfoliation Syndrome; Fema | 2018 |
6 other studies available for acetazolamide and Exfoliation Glaucoma
Article | Year |
---|---|
Reply.
Topics: Acetazolamide; Cataract; Exfoliation Syndrome; Humans; Intraocular Pressure; Tonometry, Ocular | 2018 |
Intraocular pressure elevation after phacoemulsification in eyes with pseudoexfoliation syndrome.
Topics: Acetazolamide; Capsule Opacification; Exfoliation Syndrome; Humans; Intraocular Pressure; Phacoemuls | 2018 |
Exfoliative glaucoma and primary open-angle glaucoma: associations with death causes and comorbidity.
Topics: Acetazolamide; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cause of Death; Cerebrovascul | 2004 |
Comparison of survival of exfoliative glaucoma patients and primary open-angle glaucoma patients: impact of acetazolamide use.
Topics: Acetazolamide; Age Distribution; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cause of De | 2004 |
Cataract extraction and intraocular lens implantation in eyes with phacomorphic or phacolytic glaucoma.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cataract Extraction; Exfoliatio | 1996 |
True exfoliation of the lens capsule following uveitis.
Topics: Acetazolamide; Aged; Betamethasone; Drug Therapy, Combination; Exfoliation Syndrome; Female; Humans; | 2000 |